Aytu patents expiration
1. Aciphex Sprinkle patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US5045552 | AYTU | Pyridine derivatives having anti-ulcerative activity |
May, 2013
(10 years ago) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5045552 (Pediatric) | AYTU | Pyridine derivatives having anti-ulcerative activity |
Nov, 2013
(10 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Pediatric Exclusivity(PED) | Sep 26, 2016 |
| New Dosage Form(NDF) | Mar 26, 2016 |
Drugs and Companies using RABEPRAZOLE SODIUM ingredient
Market Authorisation Date: 26 March, 2013
Treatment: Treatment of peptic ulcers
Dosage: CAPSULE, DELAYED RELEASE;ORAL
More Information on Dosage
ACIPHEX SPRINKLE family patents
2. Karbinal Er patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9522191 | AYTU | Modified release formulations containing drug—ion exchange resin complexes |
Jun, 2027
(3 years from now) | |
| US8062667 | AYTU | Modified release formulations containing drug-ion exchange resin complexes |
Mar, 2029
(4 years from now) | |
Drugs and Companies using CARBINOXAMINE MALEATE ingredient
Market Authorisation Date: 28 March, 2013
Treatment: NA
Dosage: SUSPENSION, EXTENDED RELEASE;ORAL
More Information on Dosage
KARBINAL ER family patents
3. Zolpimist patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US8236285 | AYTU | Buccal, polar and non-polar spray containing zolpidem |
Aug, 2032
(8 years from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7632517 | AYTU | Buccal, polar and non-polar spray containing zolpidem |
Oct, 2017
(6 years ago) | |
Drugs and Companies using ZOLPIDEM TARTRATE ingredient
Market Authorisation Date: 19 December, 2008
Treatment: Treatment of transient insomnia
Dosage: SPRAY, METERED;ORAL
More Information on Dosage
ZOLPIMIST family patents